MOTS-c dosage: reported doses and schedule

A peptide the body makes; injection benefits and safety remain unproven.

Also called: MOTS-C, Mitochondrial open reading frame of the 12S rRNA-c.

Mitochondrial-derived peptides · 16-amino-acid mitochondrial signaling peptide.

Typical reported dose: 5 mg every 5 days

5 mg every 5 days: 5 mg every 5 days every 5 days, under the skin. Reported by users, occasional report. Studied in: Adults reporting self-use online; age and product identity are not independently verified. (source)
10 mg once weekly: 10 mg once weekly once weekly, under the skin. Reported by users, rare report. Studied in: Adults reporting self-use online; age and product identity are not independently verified. (source)
3 mg daily report: 3 mg daily daily, under the skin. Reported by users, rare report. Studied in: Adults reporting self-use online; age and product identity are not independently verified. (source)

These are doses reported in labels, trials or user reports, not a personal plan. Check the source behind each one.

Related to MOTS-c

Humanin: A peptide the body makes; injection benefits and safety remain unproven.
Retatrutide: An experimental weekly injection with phase 3 weight-loss results.
Ipamorelin: An experimental peptide that triggers growth hormone release.
NAD+ and precursors: NAD+ helps cells use energy; wellness injection benefits remain unproven.
Tesamorelin: A peptide approved for deep abdominal fat in adults with HIV lipodystrophy.
SS-31 (elamipretide): A peptide approved for Barth syndrome muscle strength; benefit needs confirmation and broader energy benefits remain unproven.

Sources checked: 2026-10-18.

Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.